Activation of death-associated protein kinase in human peritumoral tissue: A potential therapeutic target

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


To further understand the molecular mechanisms of N-methyl-D-aspartate receptor 2B (NR2B) phosphorylation and its contribution to glioma-related seizures, we investigated the expression of death-associated protein kinase-1 (DAPK1), which is a kinase known to phosphorylate NR2B at S1303 in glioma and peritumoral tissue. The molecular mechanisms leading to glioma-associated seizures are poorly understood. We recently discovered that NR2B is phosphorylated at S1303 in glioma peritumoral tissue. NR2B is an excitatory glutamate receptor, suggesting that glutamate released from glioma tumor cells may excite the neurons in the peritumoral tissue and contribute to glioma-associated epileptogenesis. DAPK1 levels were assessed in an intracranial mouse model of human glioma and in primary patient peritumoral and glioma tissues using immunohistochemistry. DAPK1 is highly expressed in the peritumoral region, but is poorly expressed in glioma tissues in both a mouse model of human glioma and in the primary patient glioma. In our previous report, we found that NR2B is also highly phosphorylated in the same region. Upregulation of DAPK1 in the peritumoral tissues suggests that DAPK1 can phosphorylate NR2B, increase its excitability, lead to glioma-induced seizures, and could potentially be an important therapeutic target. Furthermore, the xenograft model offers an opportunity to develop and test therapeutic approaches that can block DAPK1 activity in vivo.

Original languageEnglish (US)
Article number6063
Pages (from-to)1655-1660
Number of pages6
JournalJournal of Clinical Neuroscience
Issue number10
StatePublished - Oct 1 2015


  • Death associated protein kinase 1
  • Glioblastoma multiforme
  • Peritumoral seizures

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Activation of death-associated protein kinase in human peritumoral tissue: A potential therapeutic target'. Together they form a unique fingerprint.

Cite this